The information provided about medicinal products is intended for informational purposes only and does not constitute an offer, advertisement, or instruction for use. Sale, delivery, and prescription of medications are not carried out through the website. For questions regarding the use of a medication, you can schedule an in-person appointment or online consultation with a relevant specialist at our clinic.
MOUNJARO (MUDZHARO) NIDERLANDY
Active ingredient: Tirzepatide
Mounjaro (Tirzepatide) is a modern innovative drug from Eli Lilly, developed for the treatment of type 2 diabetes. The drug not only effectively controls blood sugar levels but also has unique capabilities in combating excess weight, making it a breakthrough in its class.
Weight Loss: A Unique Advantage of the Drug
One of the main distinguishing features of Mounjaro is its ability to significantly reduce body weight. This effect is achieved through the dual mechanism of action of Tirzepatide, which affects hormones responsible for appetite and fat accumulation:
• Appetite reduction: the drug decreases hunger, helping patients consume fewer calories.
• Acceleration of fat metabolism: it stimulates the natural burning of fat deposits, leading to safe and sustainable weight loss.
Clinical studies have shown that patients taking Mounjaro lose an average of 15–20% of their body weight over a year. This makes the drug a unique solution for both type 2 diabetes patients and those suffering from obesity.
Type 2 Diabetes Treatment: Maximum Control
Mounjaro is intended for the treatment of type 2 diabetes and effectively addresses one of the main issues – blood glucose level control:
• Reduces HbA1c levels by 1.5–2.5%, ensuring the achievement of glycemic targets.
• Helps prevent diabetes complications, including damage to blood vessels, kidneys, and vision.
• Works both as monotherapy and in combination with other treatments.
Cardiovascular Benefits
An additional important effect of Mounjaro is its impact on cardiovascular health.
• Reduces the risk of complications: decreases the likelihood of heart attacks, strokes, and other cardiovascular diseases.
• Improves lipid profile: the drug helps normalize cholesterol and triglyceride levels.
How Does Mounjaro Work?
Tirzepatide is a dual agonist of GIP and GLP-1 receptors, providing a comprehensive effect on the body:
1. GIP hormone: regulates fat metabolism and reduces appetite.
2. GLP-1 hormone: stimulates insulin production, lowers blood sugar levels, and slows gastric emptying, helping control the feeling of fullness.
This combination allows patients to achieve both optimal glucose levels and significant weight loss.
Dosage Features
The drug is available in various dosages: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg, allowing doctors to tailor treatment to the individual needs of each patient.
Clinical Data and Research Results
Mounjaro has gained wide recognition in medical circles due to the following results:
• Weight loss: patients lose 10 to 20 kg over 6–12 months.
• Sugar control: over 85% of patients achieve an HbA1c level below 7%.
• Cardiovascular effects: significant reduction in the frequency of cardiovascular complications.
Usage Recommendations
1. Used in adult patients with type 2 diabetes, especially in the presence of excess weight.
2. Can be used as part of comprehensive diabetes treatment or as monotherapy.
3. Initial dose – 2.5 mg with subsequent gradual increase.
Safety and Tolerability
Mounjaro is well tolerated by most patients. Possible side effects include mild stomach upset, which resolves within the first few weeks of use.
Who is Mounjaro Suitable For?
• People with type 2 diabetes seeking improved blood sugar control.
• Patients with obesity who want to safely lose weight.
• Those aiming to improve overall health and reduce cardiovascular risks.
Why Choose Mounjaro?
• Effectiveness: one of the most powerful agents on the market.
• Innovative approach: unique mechanism of action.
• Long-term results: weight loss and sustained sugar control.
Mounjaro is a revolution in diabetes treatment and obesity management, opening the way for patients to a healthier and better quality of life.
Manufacturer: Lilly
Type: PEN INJECTOR
Weight Loss: A Unique Advantage of the Drug
One of the main distinguishing features of Mounjaro is its ability to significantly reduce body weight. This effect is achieved through the dual mechanism of action of Tirzepatide, which affects hormones responsible for appetite and fat accumulation:
• Appetite reduction: the drug decreases hunger, helping patients consume fewer calories.
• Acceleration of fat metabolism: it stimulates the natural burning of fat deposits, leading to safe and sustainable weight loss.
Clinical studies have shown that patients taking Mounjaro lose an average of 15–20% of their body weight over a year. This makes the drug a unique solution for both type 2 diabetes patients and those suffering from obesity.
Type 2 Diabetes Treatment: Maximum Control
Mounjaro is intended for the treatment of type 2 diabetes and effectively addresses one of the main issues – blood glucose level control:
• Reduces HbA1c levels by 1.5–2.5%, ensuring the achievement of glycemic targets.
• Helps prevent diabetes complications, including damage to blood vessels, kidneys, and vision.
• Works both as monotherapy and in combination with other treatments.
Cardiovascular Benefits
An additional important effect of Mounjaro is its impact on cardiovascular health.
• Reduces the risk of complications: decreases the likelihood of heart attacks, strokes, and other cardiovascular diseases.
• Improves lipid profile: the drug helps normalize cholesterol and triglyceride levels.
How Does Mounjaro Work?
Tirzepatide is a dual agonist of GIP and GLP-1 receptors, providing a comprehensive effect on the body:
1. GIP hormone: regulates fat metabolism and reduces appetite.
2. GLP-1 hormone: stimulates insulin production, lowers blood sugar levels, and slows gastric emptying, helping control the feeling of fullness.
This combination allows patients to achieve both optimal glucose levels and significant weight loss.
Dosage Features
The drug is available in various dosages: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg, allowing doctors to tailor treatment to the individual needs of each patient.
Clinical Data and Research Results
Mounjaro has gained wide recognition in medical circles due to the following results:
• Weight loss: patients lose 10 to 20 kg over 6–12 months.
• Sugar control: over 85% of patients achieve an HbA1c level below 7%.
• Cardiovascular effects: significant reduction in the frequency of cardiovascular complications.
Usage Recommendations
1. Used in adult patients with type 2 diabetes, especially in the presence of excess weight.
2. Can be used as part of comprehensive diabetes treatment or as monotherapy.
3. Initial dose – 2.5 mg with subsequent gradual increase.
Safety and Tolerability
Mounjaro is well tolerated by most patients. Possible side effects include mild stomach upset, which resolves within the first few weeks of use.
Who is Mounjaro Suitable For?
• People with type 2 diabetes seeking improved blood sugar control.
• Patients with obesity who want to safely lose weight.
• Those aiming to improve overall health and reduce cardiovascular risks.
Why Choose Mounjaro?
• Effectiveness: one of the most powerful agents on the market.
• Innovative approach: unique mechanism of action.
• Long-term results: weight loss and sustained sugar control.
Mounjaro is a revolution in diabetes treatment and obesity management, opening the way for patients to a healthier and better quality of life.
Manufacturer: Lilly
Type: PEN INJECTOR
